Markham, Canada

Xinliang Mao

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent. Top assignees: Mayo Foundation for Medical Education and Research, University Health Network. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xinliang Mao. Retrieved from https://idiyas.com/inventor/xinliang-mao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Inventor Xinliang Mao

Introduction

Xinliang Mao is a notable inventor based in Markham, Canada. He has made significant contributions to the field of biotechnology, particularly in the area of cyclin D polypeptide inhibition. His work has implications for understanding and treating various diseases.

Latest Patents

Xinliang Mao holds 1 patent related to inhibiting cyclin D polypeptides. This patent outlines methods and materials for inhibiting cyclin D polypeptide activity. It provides techniques to identify mammals or cells that require cyclin D polypeptide inhibition and administer agents capable of inhibiting this activity.

Career Highlights

Throughout his career, Xinliang Mao has worked with prestigious organizations such as the University Health Network and the Mayo Foundation for Medical Education and Research. His experience in these institutions has allowed him to collaborate with leading experts in the field.

Collaborations

Some of his notable coworkers include Rodger E. Tiedemann and Alexander Keith Stewart. Their collaborative efforts have contributed to advancements in research and innovation.

Conclusion

Xinliang Mao's work in inhibiting cyclin D polypeptides showcases his innovative spirit and dedication to advancing medical science. His contributions are valuable to the ongoing research in biotechnology and medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…